June 8, 2017August 24, 2022
Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

The antibiotic omadacycline has displayed an ability to fight treatment-resistant respiratory, skin and urinary-tract bacteria in preclinical-trial studies, according to its maker, ... Read more
June 6, 2017June 6, 2017
Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

A combination of Salvecin (AR-301) and antibiotics eradicated ventilator-associated bacterial pneumonia (VABP) better than antibiotics alone, according to a Phase ... Read more
June 1, 2017June 1, 2017
PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

The PPV23 vaccine, designed to protect against community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae, is not uniformly effective among the general ... Read more
May 30, 2017May 30, 2017
Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

A combination of three antibiotics can eradicate two of today’s six most treatment-resistant bacteria, according to researchers at the State University ... Read more
May 25, 2017May 25, 2017
Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

A new study urges hospital intensive care units (ICUs) to adopt safety and hygiene protocols to reduce the occurrence of ... Read more
May 23, 2017May 23, 2017
Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

An initial antibiotics regimen fails to cure pneumonia in one in four patients who acquire the disease outside hospitals and ... Read more
May 18, 2017May 18, 2017
Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

A key immune system component called memory T-cells contributes to the naturally occurring protection against pneumonia-causing bacteria that the body develops ... Read more
May 16, 2017May 16, 2017
Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

The risk of having a heart attack increases 17 times in the seven days after a respiratory infection, including pneumonia, ... Read more
May 11, 2017May 11, 2017
Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

Doctors Without Borders will conduct a clinical study on ResApp Health‘s respiratory disease app ResAppDx in a lower-income rural setting, the ... Read more
May 9, 2017May 9, 2017
PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

PaxVax is modernizing a pneumonia virus vaccine that hasn’t been updated in 30 years, partly to help protect military recruits. Because ... Read more
May 4, 2017May 4, 2017
T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

T-follicular helper cells generate antibodies that prevent people from getting pneumococcal pneumonia, according to a Australian study whose findings offer important ... Read more
May 2, 2017May 2, 2017
Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests

Patients with community-acquired pneumonia (CAP) and treated with penicillin-G/V had less severe pneumonia than patients treated with broad-spectrum antibiotics or ... Read more

January 31, 2017January 31, 2017

Pulmonary Center Director Wins $5.9M Grant to Further Study of Pneumonia

The director of the Pulmonary Center at Boston University’s School of Medicine has won an Outstanding Investigator Award to continue research into the biology of pneumonia. The seven-year, $5.9 million grant given Joseph P. Mizgerd by the National Heart, ... Read more

January 26, 2017January 26, 2017

Arsanis Doses First Patient in Phase 2 Trial of Therapy to Prevent S. Aureus Pneumonia

Arsanis has dosed the first patient in its Phase 2 clinical trial evaluating ASN100 as a prevention treatment for Staphylococcus aureus pneumonia in high-risk, mechanically ventilated patients. The randomized, double-blind, placebo-controlled clinical trial ... Read more

January 24, 2017January 24, 2017

Engineers Invent ‘Smart Jacket’ to Quickly Diagnose Pneumonia

Ugandan engineers have created a “smart jacket” that can diagnose pneumonia faster than a doctor by measuring breathing patterns, temperature and breathing rate simultaneously, then sending the information to a ... Read more

January 19, 2017January 19, 2017

Community-acquired Pneumonia Not ‘Seasonal Disease,’ But Can Often Strike in Winter

Cases of community-acquired pneumonia (CAP) are more frequent during the winter but can occur during other seasons, a new study says. Researchers say the condition should not be considered a ... Read more

January 17, 2017January 17, 2017

Pneumonia Bacteria Secretes Toxin to Help It Jump Between Hosts, Study Finds

Researchers have found that Streptococcus pneumoniae, the bacteria that causes most pneumonia cases, secretes a toxin to help it move from one body to the next with the help of the ... Read more

January 12, 2017January 13, 2017

A Number of Other Bacteria Found in Lungs of Legionella-pneumonia Patients, Study Shows

Sputum samples of patients hospitalized with Legionella-infected pneumonia contained a number of other bacteria and pathogens, researchers using a novel detection technique called Next Generation Sequencing have found. The study, “Comparison ... Read more

January 10, 2017January 10, 2017

Aridis’ Pneumonia Treatment AR-301 Proven Safe in Clinical Trials

The pneumonia treatment AR-301 (Salvecin) has proven safe in Phases 1 and 2 of clinical trials, its maker, Aridis Pharmaceuticals, has announced. The compound, which targets the Staphylococcus aureus alpha-toxin, is designed to be ... Read more

January 5, 2017January 5, 2017

FDA Declines to Approve Solithera as CABP Treatment, Requests Larger Safety Study

The U.S. Food and Drug Administration (FDA) has rejected applications requesting the approval of oral and intravenous Solithera (solithromycin) to treat community-acquired bacterial pneumonia (CABP) in adults, recommending instead a new and larger clinical ... Read more

January 3, 2017January 3, 2017

Women at Higher Risk for Pneumonia Linked to Drug-resistant Pathogens, Study Finds

Several risks factors have been identified as increasing the likelihood of immunocompetent patients developing pneumonia tied to drug-resistant pathogens. Female sex was reported to be a dominant risk factor, followed by a recent hospitalization. The ... Read more

December 22, 2016December 22, 2016

Scientists Learn More About Fungus Protein That Contributes to Pneumonia

Researchers have gained insight into a protein that allows the survival of the fungus Pneumocystis, which causes lethal pneumonia infections in those with weak immune systems, according to a new ... Read more

December 20, 2016December 20, 2016

Clinical Trial to Test Mobile App’s Ability to Diagnose Pneumonia in Babies and Children

ResApp Health announced the launch of its SMARTCOUGH-C clinical study in the United States, evaluating the efficacy of ResAppDx, a mobile application designed to aid in the diagnosis of childhood pneumonia and ... Read more

December 15, 2016December 15, 2016

Study: Analyzing Bronchoalveolar Lavage (BAL) Fluid Helps Diagnose Lung Diseases, Pneumonia

A new study confirms that analyzing the BAL fluid (bronchoalveolar lavage fluid in the lungs’ bronchi) is a valuable tool to help doctors properly diagnosis patients with lung diseases, including ... Read more

Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests